Effect of soybean on breast cancer according to receptor status: A case–control study in Japan

The possible association of high soy food consumption with low incidence of breast cancer in Asian countries has been widely investigated, but findings from epidemiologic studies have been inconsistent. Breast cancers defined by receptor status, estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) may have distinct etiologic factors. Here, we conducted a case–control study to clarify associations between intake of soybean products and breast cancer risk according to receptor status. A total of 678 breast cancer cases and 3,390 age‐ and menopausal status‐matched noncancer controls were included. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated using conditional logistic models adjusted for potential confounders. On analysis according to receptor status, we observed a significantly reduced risk of ER‐positive (ER+) (top tertile OR = 0.74; 95% CI, 0.58–0.94; trend p = 0.01) and HER2‐negative (HER2−) tumors (top tertile OR = 0.78; 95% CI, 0.61–0.99; trend p = 0.04). Further, when the 3 receptors were jointly examined, a reduced risk was observed only in patients with ER+/PR+/HER2− tumor (top tertile OR = 0.73; 95% CI, 0.54–0.97; trend p = 0.03). These findings indicate that the protective effect of soy against breast cancer risk differs by receptor status. © 2008 Wiley‐Liss, Inc.

[1]  M. J. van de Vijver,et al.  The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  D. Ingram,et al.  Case-control study of phyto-oestrogens and breast cancer , 1997, The Lancet.

[3]  M. Inoue,et al.  Subsite-specific risk factors for colorectal cancer: a hospital-based case-control study in Japan , 2004, Cancer Causes & Control.

[4]  J. Hartman,et al.  Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D , 2004 .

[5]  Meir J. Stampfer,et al.  Total energy intake: implications for epidemiologic analyses. , 1986, American journal of epidemiology.

[6]  C. Goto,et al.  Reproducibility of a Short Food Frequency Questionnaire for Japanese General Population , 2007, Journal of epidemiology.

[7]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[8]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[9]  B. Trock,et al.  Meta-analysis of soy intake and breast cancer risk. , 2006, Journal of the National Cancer Institute.

[10]  W. Thompson,et al.  Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  R C Millikan,et al.  Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. , 2000, American journal of epidemiology.

[12]  A M Nomura,et al.  Tofu and risk of breast cancer in Asian-Americans. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  M. Inoue,et al.  Epidemiological features of first-visit outpatients in Japan: comparison with general population and variation by sex, age, and season. , 1997, Journal of clinical epidemiology.

[14]  P. Porter,et al.  Food and botanical groupings and risk of breast cancer: a case-control study in Shanghai, China. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  M. García-Closas,et al.  Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[16]  Maria Parpinel,et al.  Flavonoids and Breast Cancer Risk in Italy , 2005, Cancer Epidemiology Biomarkers & Prevention.

[17]  M. Sliwkowski,et al.  HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. , 1995, Oncogene.

[18]  A. Trentham-Dietz,et al.  Oral Contraceptive Use, Reproductive Factors, and Colorectal Cancer Risk: Findings from Wisconsin , 2005, Cancer Epidemiology Biomarkers & Prevention.

[19]  V. McCormack,et al.  Phyto-oestrogen Intake and Breast Cancer Risk in South Asian Women in England: Findings from a Population-based Case-Control Study , 2004, Cancer Causes & Control.

[20]  G. Maskarinec,et al.  Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  S. Tsugane,et al.  Soy, isoflavones, and breast cancer risk in Japan. , 2003, Journal of the National Cancer Institute.

[22]  Mitch Dowsett,et al.  Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  D. Leitman,et al.  Estrogen Receptor β-Selective Transcriptional Activity and Recruitment of Coregulators by Phytoestrogens* , 2001, The Journal of Biological Chemistry.

[24]  J. Potter,et al.  Population-based case–control study of soyfood intake and breast cancer risk in Shanghai , 2001, British Journal of Cancer.

[25]  M. Inoue,et al.  A Model of Practical Cancer Prevention for Out-patients Visiting a Hospital: the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). , 2000, Asian Pacific journal of cancer prevention : APJCP.

[26]  E. Perez-stable,et al.  Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. , 2001, American journal of epidemiology.

[27]  G A Colditz,et al.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. , 1995, The New England journal of medicine.

[28]  J. Chang-Claude,et al.  Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case‐control study , 2004, International journal of cancer.

[29]  B. Henderson,et al.  Diet and breast cancer in Shanghai and Tianjin, China. , 1995, British Journal of Cancer.

[30]  H. Yatsuya,et al.  Consumption of soy foods and the risk of breast cancer: findings from the Japan Collaborative Cohort (JACC) Study , 2007, Cancer Causes & Control.

[31]  V. Beral,et al.  Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan , 1999, British Journal of Cancer.

[32]  R. Millikan,et al.  Risk of breast cancer according to the status of HER-2/neu oncogene amplification. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  L. Bernstein,et al.  Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[34]  R. Margueron,et al.  Ligands Differentially Modulate the Protein Interactions of the Human Estrogen Receptors α and β , 2003 .

[35]  S. Tokudome,et al.  Development of data-based semi-quantitative food frequency questionnaire for dietary studies in middle-aged Japanese. , 1998, Japanese journal of clinical oncology.

[36]  C. Goto,et al.  Relative Validity of a Short Food Frequency Questionnaire for Assessing Nutrient Intake versus Three-day Weighed Diet Records in Middle-aged Japanese , 2005, Journal of epidemiology.

[37]  V. McCormack,et al.  Lifelong vegetarianism and risk of breast cancer: A population‐based case‐control study among South Asian migrant women living in England , 2002, International journal of cancer.

[38]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[39]  R. Margueron,et al.  Ligands differentially modulate the protein interactions of the human estrogen receptors alpha and beta. , 2003, Journal of molecular biology.

[40]  J. Hartman,et al.  Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[41]  K. Matsuo,et al.  Soybean products and reduction of breast cancer risk: a case–control study in Japan , 2005, British Journal of Cancer.

[42]  S. Duffy,et al.  Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore , 1992, Cancer Causes & Control.

[43]  Graham A Colditz,et al.  Risk factors for breast cancer according to estrogen and progesterone receptor status. , 2004, Journal of the National Cancer Institute.

[44]  I. Andrulis,et al.  HER‐2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry , 2002, Cancer.

[45]  A. Trentham-Dietz,et al.  Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[46]  H. Anton-Culver,et al.  Recent diet and breast cancer risk: the California Teachers Study (USA) , 2002, Cancer Causes & Control.

[47]  A. Bianco,et al.  c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  K. Matsuo,et al.  Gene-environment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II). , 2001, Asian Pacific journal of cancer prevention : APJCP.

[49]  E. Wynder,et al.  Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. , 1991, International journal of epidemiology.

[50]  M. Pike,et al.  Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. , 2002, Carcinogenesis.

[51]  P. Hudak,et al.  Evaluation of ecological and in vitro effects of boron on prostate cancer risk (United States) , 2007, Cancer Causes & Control.